国际慢性稳定性心绞痛的演变和结局的观察性分析:多国 CLARIFY 研究。
International Observational Analysis of Evolution and Outcomes of Chronic Stable Angina: The Multinational CLARIFY Study.
机构信息
Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, France (J.M., G.D., P.G.S.).
French Alliance for Cardiovascular Trials, Paris (J.M., G.D., P.G.S.).
出版信息
Circulation. 2021 Aug 17;144(7):512-523. doi: 10.1161/CIRCULATIONAHA.121.054567. Epub 2021 Jul 15.
BACKGROUND
Although angina is common in patients with stable coronary artery disease, limited data are available on its prevalence, natural evolution, and outcomes in the era of effective cardiovascular drugs and widespread use of coronary revascularization.
METHODS
Using data from 32 691 patients with stable coronary artery disease from the prospective observational CLARIFY registry (Prospective Observational Longitudinal Registry of Patients with Stable Coronary Artery Disease), anginal status was mapped each year in patients without new coronary revascularization or new myocardial infarction. The use of medical interventions in the year preceding angina resolution was explored. The effect of 1-year changes in angina status on 5-year outcomes was analyzed using multivariable analysis.
RESULTS
Among 7212 (22.1%) patients who reported angina at baseline, angina disappeared (without coronary revascularization) in 39.6% at 1 year, with further annual decreases. In patients without angina at baseline, 2.0% to 4.8% developed angina each year. During 5-year follow-up, angina was controlled in 7773 patients, in whom resolution of angina was obtained with increased use of antianginal treatment in 11.1%, with coronary revascularization in 4.5%, and without any changes in medication or revascularization in 84.4%. Compared to patients without angina at baseline and 1 year, persistence of angina and occurrence of angina at 1 year with conservative management were each independently associated with higher rates of cardiovascular death or myocardial infarction (adjusted hazard ratio, 1.32 [95% CI, 1.12-1.55] for persistence of angina; adjusted hazard ratio, 1.37 [95% CI, 1.11-1.70] for occurrence of angina) at 5 years. Patients whose angina had resolved at 1 year with conservative management were not at higher risk of cardiovascular death or myocardial infarction than those who never experienced angina (adjusted hazard ratio, 0.97 [95% CI, 0.82-1.15]).
CONCLUSIONS
Angina affects almost one-quarter of patients with stable coronary artery disease but resolves without events or coronary revascularization in most patients. Resolution of angina within 1 year with conservative management predicted outcomes similar to lack of angina, whereas persistence or occurrence was associated with worse outcomes. Because most patients with angina are likely to experience resolution of symptoms, and because there is no demonstrated outcome benefit to routine revascularization, this study emphasizes the value of conservative management of stable coronary artery disease. Registration: URL: https://www.isrctn.com; Unique identifier: ISRCTN43070564.
背景
尽管稳定型冠状动脉疾病患者中常出现心绞痛,但在有效心血管药物和广泛应用冠状动脉血运重建的时代,关于其患病率、自然演变和结局的数据有限。
方法
利用来自前瞻性观察性 CLARIFY 登记研究(前瞻性观察性稳定型冠状动脉疾病患者登记研究)32691 例稳定型冠状动脉疾病患者的数据,对无新发冠状动脉血运重建或新发心肌梗死的患者,每年对心绞痛状态进行映射。探讨心绞痛缓解前一年中医疗干预措施的应用。采用多变量分析,分析心绞痛状态 1 年变化对 5 年结局的影响。
结果
在 7212 例(22.1%)基线时报告心绞痛的患者中,39.6%的患者在 1 年内(未经冠状动脉血运重建)心绞痛消失,且每年进一步下降。在基线时无心绞痛的患者中,每年有 2.0%至 4.8%的患者出现心绞痛。在 5 年随访期间,7773 例患者的心绞痛得到控制,其中 11.1%通过增加抗心绞痛治疗、4.5%通过冠状动脉血运重建、84.4%通过药物或血运重建无任何变化而缓解心绞痛。与基线和 1 年时无心绞痛的患者相比,持续存在心绞痛和保守治疗 1 年时发生心绞痛与心血管死亡或心肌梗死的发生率较高相关(校正后的风险比为 1.32 [95%CI,1.12-1.55],用于持续存在心绞痛;校正后的风险比为 1.37 [95%CI,1.11-1.70],用于发生心绞痛)。在保守治疗下心绞痛在 1 年内缓解的患者,心血管死亡或心肌梗死的风险并不高于从未经历过心绞痛的患者(校正后的风险比为 0.97 [95%CI,0.82-1.15])。
结论
心绞痛影响近四分之一的稳定型冠状动脉疾病患者,但在大多数患者中无需事件或冠状动脉血运重建即可缓解。1 年内通过保守治疗缓解心绞痛可预测与无心绞痛相似的结局,而持续存在或发生心绞痛与较差的结局相关。由于大多数有胸痛的患者可能会缓解症状,而且常规血运重建也没有显示出获益,因此这项研究强调了稳定型冠状动脉疾病保守治疗的价值。